Previous Article | Next Article ![]()
J Virol, May 1998, p. 4297-4307, Vol. 72, No. 5
Department of Biological Chemistry,
University of California
Received 14 November 1996/Accepted 26 January 1998
This report describes the results of experiments to determine
whether chimeras between a retrovirus and portions of Ty3 are active in
vivo. A chimera between Ty3 and a Neor-marked Moloney
murine leukemia virus (M-MuLV) was constructed. The C-terminal domain
of M-MuLV integrase (IN) was replaced with the C-terminal domain of Ty3
IN. The chimeric retroviruses were expressed from an amphotrophic
envelope packaging cell line. The virus generated was used to infect
the human fibrosarcoma cell line HT1080, and cells in which integration
had occurred were selected by G418 resistance. Three independently
integrated viruses were rescued. In each case, the C-terminal Ty3 IN
sequences were maintained and short direct repeats of the genomic DNA
flanked the integration site. Sequence analysis of the genomic DNA
flanking the insertion did not identify a tRNA gene; therefore, these
integration events did not have Ty3 position specificity. This study
showed that IN sequences from the yeast retrovirus-like element Ty3 can substitute for M-MuLV IN sequences in the C-terminal domain and contribute to IN function in vivo. It is also one of the first in vivo
demonstrations of activity of a retrovirus encoding an integrase
chimera. Studies of chimeras between IN species with distinctive
integration patterns should complement previous work by expanding our
understanding of the roles of nonconserved domains.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
A Chimeric Ty3/Moloney Murine Leukemia Virus
Integrase Protein Is Active In Vivo
Irvine, Irvine, California
92697-1700,1 and
Center for Gene
Therapy, Chiron Technologies, San Diego, California 92121
*
Corresponding author. Mailing address: Department of
Biological Chemistry, College of Medicine, University of
California
Irvine, Irvine, CA 92697-1700. Phone: (714) 824-7571. Fax:
(714) 824-2688. E-mail: sbsandme{at}uci.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|